City Holding CO Eli Lilly & CO Transaction History

City Holding CO

$690 Million
Q3 2024

A detailed history of City Holding CO transactions in Eli Lilly & CO stock. As of the latest transaction made, City Holding CO holds 25,031 shares of LLY stock, worth $19.2 Million. This represents 3.21% of its overall portfolio holdings.

Number of Shares

25,031

Previous 26,578 5.82%

Holding current value

$19.2 Million

Previous $24.1 Million 7.85%

% of portfolio

3.21%

Previous 3.7%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2024	SELL	$772.14 - $960.02 $1.19 Million - $1.49 Million	-1,547 Reduced 5.82%	25,031 $22.2 Million
Q2 2024 Jul 12, 2024	SELL	$724.87 - $909.04 $639,335 - $801,773	-882 Reduced 3.21%	26,578 $24.1 Million
Q1 2024 Apr 11, 2024	SELL	$592.2 - $792.28 $955,218 - $1.28 Million	-1,613 Reduced 5.55%	27,460 $21.4 Million
Q4 2023 Jan 10, 2024	SELL	$525.19 - $619.13 $460,591 - $542,977	-877 Reduced 2.93%	29,073 $16.9 Million
Q3 2023 Oct 13, 2023	SELL	$434.7 - $599.3 $1.09 Million - $1.5 Million	-2,506 Reduced 7.72%	29,950 $16.1 Million
Q2 2023 Jul 13, 2023	SELL	$350.74 - $468.98 $303,039 - $405,198	-864 Reduced 2.59%	32,456 $15.2 Million
Q1 2023 Apr 17, 2023	SELL	$310.63 - $364.82 $362,505 - $425,744	-1,167 Reduced 3.38%	33,320 $11.4 Million
Q4 2022 Jan 27, 2023	SELL	$321.55 - $374.67 $327,016 - $381,039	-1,017 Reduced 2.86%	34,487 $0
Q3 2022 Oct 12, 2022	SELL	$296.48 - $337.87 $686,054 - $781,831	-2,314 Reduced 6.12%	35,504 $11.5 Million
Q2 2022 Jul 08, 2022	SELL	$278.73 - $327.27 $537,670 - $631,303	-1,929 Reduced 4.85%	37,818 $12.3 Million
Q1 2022 Apr 15, 2022	SELL	$234.69 - $291.66 $5,867 - $7,291	-25 Reduced 0.06%	39,747 $11.4 Million
Q4 2021 Mar 11, 2022	BUY	$224.85 - $279.04 $53,289 - $66,132	237 Added 0.6%	39,772 $9.94 Million
Q3 2021 Oct 15, 2021	SELL	$221.6 - $272.71 $4,432 - $5,454	-20 Reduced 0.05%	39,535 $9.13 Million
Q2 2021 Jul 15, 2021	BUY	$180.55 - $233.54 $123,135 - $159,274	682 Added 1.75%	39,555 $9.08 Million
Q1 2021 Apr 15, 2021	BUY	$164.32 - $212.72 $61,291 - $79,344	373 Added 0.97%	38,873 $7.26 Million
Q4 2020 Jan 12, 2021	BUY	$130.46 - $172.63 $253,744 - $335,765	1,945 Added 5.32%	38,500 $6.5 Million
Q3 2020 Oct 08, 2020	BUY	$146.22 - $169.13 $31,437 - $36,362	215 Added 0.59%	36,555 $5.41 Million
Q2 2020 Jul 13, 2020	BUY	$136.42 - $164.18 $112,819 - $135,776	827 Added 2.33%	36,340 $5.97 Million
Q1 2020 Apr 16, 2020	SELL	$119.05 - $147.35 $40,715 - $50,393	-342 Reduced 0.95%	35,513 $4.93 Million
Q4 2019 Jan 10, 2020	BUY	$106.92 - $132.43 $39,453 - $48,866	369 Added 1.04%	35,855 $4.71 Million
Q3 2019 Oct 15, 2019	BUY	$106.79 - $116.16 $18,154 - $19,747	170 Added 0.48%	35,486 $3.97 Million
Q2 2019 Jul 16, 2019	SELL	$110.79 - $129.32 $997 - $1,163	-9 Reduced 0.03%	35,316 $3.91 Million
Q1 2019 Apr 17, 2019	BUY	$111.31 - $131.02 $59,550 - $70,095	535 Added 1.54%	35,325 $4.58 Million
Q4 2018 Jan 18, 2019	SELL	$105.9 - $118.64 $1,059 - $1,186	-10 Reduced 0.03%	34,790 $4.03 Million
Q3 2018 Oct 15, 2018	SELL	$85.86 - $107.31 $23,611 - $29,510	-275 Reduced 0.78%	34,800 $3.73 Million
Q2 2018 Aug 20, 2018	SELL	$75.7 - $86.88 $19,682 - $22,588	-260 Reduced 0.74%	35,075 $2.99 Million
Q1 2018 Apr 12, 2018	BUY	$74.21 - $87.6 $155,841 - $183,960	2,100 Added 6.32%	35,335 $2.73 Million
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $18,600 - $19,951	-227 Reduced 0.68%	33,235 $2.81 Million
Q3 2017 Oct 17, 2017	BUY	$77.07 - $85.54 $2.58 Million - $2.86 Million	33,462	33,462 $2.86 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of City Holding CO, based on Form 13F filings with the SEC.

News

Stay updated on City Holding CO with notifications on news.

Account